AN IMMUNOHISTOCHEMICAL ANALYSIS OF 13 CASES WITH COMBINED HEPATOCELLULAR AND CHOLANGIOCELLULAR CARCINOMA
Citation
J. Haratake et H. Hashimoto, AN IMMUNOHISTOCHEMICAL ANALYSIS OF 13 CASES WITH COMBINED HEPATOCELLULAR AND CHOLANGIOCELLULAR CARCINOMA, Liver, 15(1), 1995, pp. 9-15
Categorie Soggetti
Gastroenterology & Hepatology
SICI code
0106-9543(1995)15:1<9:AIAO1C>2.0.ZU;2-3
Abstract
Thirteen cases of combined hepatocellular (HCC) and cholangiocellular
carcinoma (CCC) were examined. In addition to routine pathology, immun
oreactivities for carcinoembryonic antigen, alpha-fetoprotein (AFP), c
ytokeratin (Cam 5.2 and AE1), epithelial membrane antigen (EMA) and tu
mor-associated glycoprotein 72 (B72.3) were also examined. The average
age of the 13 cases was 64.8 years, which lay between the average age
s of pure HCC and CCC cases. They were categorized as separate type (2
), collision type (6), and intermingled type (5). AE1 and EMA were the
best markers to differentiate the CCC from the HCC area. B72.3 immuno
reactivity was detected only in CCC (46%). There were no transitional
features between HCC and CCC in two cases of the separate type and two
cases of the collision type. However, focal transitional features fro
m HCC to CCC were observed in all cases of the intermingled type and i
n four of six cases of the collision type. In one case of the intermin
gled type, many cancer cells contained both bile and mucus simultaneou
sly, and revealed dual immunoreactivities. The conclusions are: 1) the
combined type is generated from two sources; one is the intrahepatic
double cancer (thoroughly separate type and a part of the collision ty
pe) and another is the stem cell origin with diverse phenotypes (inter
mingled type and a part of the collision tumor); and 2) AE1 was the mo
st helpful marker to differentiate the CCC area from HCC, and other ma
rkers, e.g. AFP for HCC and EMA, CEA, and B72.3 for CCC, were also sup
portive but somewhat limited in the differential diagnosis.